FDA New Analysis on PD Psychosis Treatment Posted on September 25, 2018September 27, 2018 by Nancy Braun FDA New Analysis on PD Psychosis Treatment On September 20, 2018, the FDA recently released results of a new analysis finding no new or unexpected safety risks associated with Nuplazid. The new analysis was initiated because of concerns raised in the media last spring, and reassures patients that they should continue to take Nuplazid as prescribed by their physician. The FDA report highlights a number of important concepts Read More
APDA Center for Advanced Research at University of Alabama School of Medicine Receives Udall Center Designation Posted on September 21, 2018December 17, 2018 by Nancy Braun APDA Center for Advanced Research at University of Alabama School of Medicine Receives Udall Center Designation Read More
APDA funded research suggests new approach to understanding the basic biology of PD Posted on August 13, 2018August 15, 2018 by Phil Franchina APDA funded research suggests new approach to understanding the basic biology of PD APDA-funded research conducted by Dr. Talene Yacoubian of the University of Alabama School of Medicine at Birmingham – one of APDA’s Centers for Advanced Research – suggests a new approach to understanding the basic biology of Parkinson’s disease. Read More
Dr. Rebecca Gilbert on Wisconsin Public Radio Posted on August 7, 2018September 27, 2018 by Nancy Braun Let’s Talk About Parkinson’s Disease with Dr. Rebecca Gilbert On Monday, August 6, 2018 Dr. Rebecca Gilbert joined the the Wisconsin Public Radio’s The Morning Show where she helps make complex things about PD simple to understand.. Read More
Dr. Gilbert Comments in Scientific American Magazine Posted on August 6, 2018August 6, 2018 by Nancy Braun Dr. Gilbert comments on Scientific American Magazine APDA’s Chief Scientific Officer Dr. Rebecca Gilbert spoke to Scientific American magazine about recent research on LRKK2 and what it could mean for both people with LRKK2 mutation and, importantly, for those who do not carry the mutation. Read More
Promising results from APDA-funded LRRK2 research Posted on August 2, 2018 by Nancy Braun Promising results from APDA-funded LRRK2 research On July 25, 2018, the APDA Center for Advanced Research at the University of Pittsburgh, led by the Center’s Director (and APDA Scientific Advisory Board member), Dr. J. Timothy Greenamyre, published results of a study highlighting the role of Leucine-rich Repeat Kinase (LRRK2) in the development of Parkinson’s disease. Read More
Compelling stem cell research in Japan about to begin Posted on August 2, 2018April 3, 2019 by Nancy Braun Compelling stem cell research in Japan about to begin On July 30, 2018, Kyoto University announced that a clinical trial using stem cells to treat Parkinson’s disease is set to begin. Read More
APDA VP and Chief Scientific Officer Dr Rebecca Gilbert On Alan Alda Parkinson’s Disease Diagnosis Posted on August 1, 2018August 2, 2018 by Nancy Braun APDA in the News Dr. Rebecca Gilbert interviewed on Boston Herald Radio in response to Alan Alda’s diagnosis announcement. Read More
Parkinson’s disease Prevalence Study Posted on July 17, 2018July 17, 2018 by Nancy Braun New Parkinson’s disease prevalence study Trying to estimate the number of people living with Parkinson’s disease (PD) in North America is extremely important but notoriously difficult. It is critical to know the prevalence of PD because it informs lawmakers who make decisions concerning allocation of research funds about the true impact of the disease, and […] Read More
Deep Brain Stimulation May Slow Tremor Progression Posted on July 6, 2018July 6, 2018 by Nancy Braun Deep brain stimulation may slow the progression of tremor if performed in early Parkinson’s disease. APDA funding is helping further the efforts to find out more. New results, published in the June 29, 2018, online issue of Neurology suggest that deep brain stimulation (DBS) may slow the progression of tremor if performed early on in […] Read More
